Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression

MiR-182 expression was evaluated by qRT-PCR and in situ hybridization in 20 tubular adenomas, 50 colorectal carcinoma (CRC), and 40 CRC liver metastases. Control samples obtained from patients with irritable bowel syndrome, or tumor-matched normal colon mucosa were analyzed (n=50). MiR-182 expressio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Perilli, Lisa, Vicentini, Caterina, Agostini, Marco, Pizzini, Silvia, Pizzi, Marco, D'Angelo, Edoardo, Bortoluzzi, Stefania, Mandruzzato, Susanna, Mammano, Enzo, Rugge, Massimo, Nitti, Donato, Scarpa, Aldo, Fassan, Matteo, Zanovello, Paola
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2014
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196150/
https://ncbi.nlm.nih.gov/pubmed/25115394
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars